Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy
2003
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
The relationship between prognostic and predictive factors in the management of breast cancer
1998
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
2005
Serial serum c-erbB-2 levels in patients with breast carcinoma
1996
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
2015
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Dissecting the metastatic cascade
2004
Patterns of metastatic breast carcinoma: influence of tumour histological grade
2004
Detection of micrometastatic cells in breast cancer by RT-PCR for the mammaglobin gene
2002
Cellular and molecular basis of preferential metastasis of breast cancer to bone
2000
Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness
2005
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
2011
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Necroptosis and its role in inflammation
2015 StandoutNature
Bone marrow micrometastases in 109 breast cancer patients: Correlations with clinical and pathological features and prognosis
1997
Prognostic Significance of Occult Bone Marrow Micrometastases of Breast Cancer Detected by Quantitative Polymerase Chain Reaction for Cytokeratin 19 mRNA
2000
Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19
2000
Detection of Breast Cancer micrometastases in peripheral blood using immunomagnetic separation and immunocytochemistry
2001
Cancer to bone: a fatal attraction
2011 Standout
Minimal Residual Disease in Bone Marrow and Peripheral Blood of Patients with Metastatic Breast Cancer
2003
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
2007
Crystal structure of parallel quadruplexes from human telomeric DNA
2002 StandoutNature
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis
2007 Nature
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Human telomerase inhibition by substituted acridine derivatives
1999
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
2003
REVIEW: Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR)
2000
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process
2005
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
A real-time quantitative reverse transcriptase polymerase chain reaction (RT–PCR) to detect breast carcinoma cells in peripheral blood
2001
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
2009
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Evaluation of breast tumour cell contamination in the bone marrow and leukapheresis collections by RT‐PCR for cytokeratin‐19 mRNA
1998
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
The role of the E6-p53 interaction in the molecular pathogenesis of HPV
1999
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Bone metastases from breast carcinoma: histopathological – radiological correlations and prognostic features
2003
Models, mechanisms and clinical evidence for cancer dormancy
2007
Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
2009
Significance, detection and markers of disseminated breast cancer cells
2006
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
2013
Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-up
1998
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Principles of adoptive T cell cancer therapy
2007
Molecular Determinants of Occult Metastatic Tumor Cells in Bone Marrow
2001
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
2000
Cancer vaccines: between the idea and the reality
2003
The natural history of cervical HPV infection: unresolved issues
2006
Osteoclast differentiation and activation
2003 StandoutNature
Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
1998
The evolving role of bisphosphonates
2001
Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice
2004
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene
1996
Dormancy in breast cancer
2012
Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma
2003
Bone marrow micrometastases in breast cancer patients
1999
Future directions of bone-targeted therapy for metastatic breast cancer
2010
Osteopontin: An Effector and an Effect of Tumor Metastasis
2010
Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
1999
Clonal evolution in cancer
2012 StandoutNature
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
1999
Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up
1994
Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance
2004
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
1998
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Missed micrometastatic disease in breast cancer
2004
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
The potential role of bisphosphonates in prostate cancer
2002
Comprehensive Integration of Single-Cell Data
2019 Standout
An Alternative Form of Replication Protein A Expressed in Normal Human Tissues Supports DNA Repair
2009 StandoutNobel
Novel approaches to target the microenvironment of bone metastasis
2021
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Breast cancer metastasis: markers and models
2005 Standout
Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro
2006
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
2008
Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
2000
Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
2005
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
2007
Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System
2004
Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells
2001 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
2003
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
Lack of Effect of Adjuvant Chemotherapy on the Elimination of Single Dormant Tumor Cells in Bone Marrow of High-Risk Breast Cancer Patients
2000
The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
2001
Advancing Treatment for Metastatic Bone Cancer: Consensus Recommendations from the Second Cambridge Conference
2008
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women
2001
Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory
2014
Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
2002
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Bisphosphonate treatment inhibits the growth of prostate cancer cells.
2001
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Tumor Cell Interactions With the Microvasculature
2001
Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
2001
Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
2002
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
2010
Immune-mediated dormancy: an equilibrium with cancer
2008
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients
2004
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Metabolic reprogramming and cancer progression
2020 StandoutScience
Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
1999
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients
2006
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.
2000
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Detection of Circulating Tumor Cells by Reverse Transcriptase Polymerase Chain Reaction of Maspin in Patients With Breast Cancer Undergoing Conventional-Dose Chemotherapy
2000
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
2000
Adjuvant Clodronate Treatment Does Not Reduce the Frequency of Skeletal Metastases in Node-Positive Breast Cancer Patients: 5-Year Results of a Randomized Controlled Trial
2001
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Comparative Analysis of Micrometastasis to the Bone Marrow and Lymph Nodes of Node-Negative Breast Cancer Patients Receiving No Adjuvant Therapy
2001
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Detection of Breast Cancer Cells in the Bone Marrow or Peripheral Blood: Methods and Prognostic Significance
2000
A Mouse Model of Human Breast Cancer Metastasis to Human Bone
2005
Hypoxia in Breast Cancer
2006
Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology.
2003
Response of Circulating Tumor Cells to Systemic Therapy in Patients With Metastatic Breast Cancer: Comparison of Quantitative Polymerase Chain Reaction and Immunocytochemical Techniques
2000
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
2001
Detection and clinical implications of early systemic tumor cell dissemination in breast cancer.
2003
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
2001
Works of G. Bastert being referenced
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow
2001
Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow—a long-term follow-up
2008
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
2002
Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
1999
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
1992
Treatment of Metastatic Bone Disease in Breast Cancer: Bisphosphonates
2000
Bisphosphonates and the prevention of metastasis
2000
Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19
2000
Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment
1998
Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors
2004
Gene Amplification and Expression of the <i>neu </i>(c-erbB-2) Sequence in Human Mammary Carcinoma
1988
Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
1997
Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression
2003
Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products
1999
Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow
1999
Results of iliac crest biopsies taken from 1465 patients with primary breast cancer
1998
Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer
1998
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
2000
Micrometastatic Breast Cancer Cells in Bone Marrow at Primary Surgery: Prognostic Value in Comparison With Nodal Status
1996
Evaluation of MUC1 and EGP40 in bone marrow and peripheral blood as a marker for occult breast cancer
2001
Prognostische Bedeutung des Tumorzellnachweises im Knochenmark im Vergleich zum Nodalstatus beim primären Mammakarzinom
1997
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
2001
[Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma].
1996
Monoclonal antibodies to detect breast cancer cells in bone marrow.
1994
Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates.
2007
Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors
2004
Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.
2003
Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients
2001
Tumor cell detection in breast cancer patients before and after neoadjuvant chemotherapy
1997
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
1999
Identification of the human papillomavirus type 18 E6 and E6 proteins in nuclear protein fractions from human cervical carcinoma cells grown in the nude mouse or in vitro.
1988
Immunoscintigraphy of human mammary carcinoma xenografts using monoclonal antibodies 12H12 and BM-2 labeled with 99mTc and radioiodine.
1994
Micrometastatic tumor cells in bone marrow versus nodal status in breast cancer—Impact on prognosis in patients with primary breast cancer
1995
DNA Aneuploidy and Integration of Human Papillomavirus Type 16 E6/E7 Oncogenes in Intraepithelial Neoplasia and Invasive Squamous Cell Carcinoma of the Cervix Uteri
2004
Angiogenesis as a Diagnostic Factor in Primary Breast Cancer: Microvessel Quantitation by Stereological Methods and Correlation with Color Doppler Sonography
1994